Skip to content

Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes

Evaluating the Impact of COVID-19 on Research in Care Homes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04716972
Enrollment
7
Registered
2021-01-20
Start date
2021-04-14
Completion date
2022-07-30
Last updated
2022-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

During the COVID-19 (corona virus) pandemic the research arena has had to rapidly adapt and change in order to facilitate and deliver research. The UK (United Kingdom) government and Public Health England have stressed the importance of such research to find solutions to treating, preventing and stopping the spread of COVID-19. Due to national and international 'lock down restrictions' delivering research in care home settings has become even more challenging. The adaptations to conducting consultations have relied heavily on the use of technology, for example video calling, telephone, email, and teleconferencing. It is suggested that the use of technology in care home settings is already a barrier to effective research delivery. Nevertheless, as care home residents are a vulnerable group, it is critical to include these groups in research in order to enable improved and evidence-based care and their access to new and emerging treatments. This study aims to assess the opinions and experiences of key stakeholders to identify barriers, and enable better facilitation of research in these settings during and post pandemic.

Detailed description

This two phase project will use a mixed methodology. Phase one will involve mixed methods surveys. One will be completed by care home residents and the other will be completed by research delivery staff and care home staff. Phase two will involve qualitative interviews with each of these groups to enable better insight into their views and opinions on research in this area.

Interventions

OTHERsurvey

Online survey

OTHERInterview

Interview

Sponsors

The Royal Wolverhampton Hospitals NHS Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Any resident of a care home in the West Midlands * Any relative/friend of a care home resident in the West Midlands * Any staff member or volunteer working in care home in the West Midlands * Any researcher undertaking research in a care home in the West Midlands (during the pandemic or proposed during the pandemic period)

Exclusion criteria

* Individuals who are unable to give Informed Consent * Individuals who lack capacity

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of vaccine studies in the care home setting through feedback questionnaire with loose themes and no unique measurements.6 monthsTo inform the design and delivery of vaccine studies in the care home setting, ensuring they are acceptable by key stakeholders
Acceptability of vaccine studies in the care home setting through feedback interview with loose themes and no unique measurements6 monthsTo inform the design and delivery of vaccine studies in the care home setting, ensuring they are acceptable by key stakeholders
Acceptability of new ways of delivering research through explorative interview with loose themes and no unique measurements6 monthsTo inform and assess the acceptability of new ways of delivering research in care home settings, guiding changes and implementation of new ways of working moving forward
Acceptability of new ways of delivering research through explorative questionnaire with loose themes and no unique measurements6 monthsTo inform and assess the acceptability of new ways of delivering research in care home settings, guiding changes and implementation of new ways of working moving forward

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026